First Tracks (TRAX) Director Ware J. Anthony Exercises Options, Sells Shares

What Happened
Ware J. Anthony, a director of First Tracks Biotherapeutics (TRAX), exercised options to acquire 39,265 shares at $5.74 per share (total cost $225,381) on September 2, 2026, and promptly sold those 39,265 shares in the open market for a weighted-average price of $44.78 per share (total proceeds ~$1,758,145). The Form 4 also reports two additional derivative dispositions on the same date for 28,571 and 10,694 shares reported at $0.00 (these are listed as derivative conversions/dispositions).

Key Details

• Transaction date: 2026-09-02; Form 4 filed 2026-09-04 (timely filing).
• Exercise: 39,265 shares acquired at $5.74 each (total cash paid $225,381). Option reported as fully vested (footnote F2).
• Sale: 39,265 shares sold in multiple trades at a weighted-average price of $44.78 (~$1,758,145 total). Sale prices ranged $44.62–$45.28 per share (footnote F1).
• Other derivative items: Dispositions of 28,571 and 10,694 derivative shares reported at $0.00 on the same date (listed as exercises/conversions, no cash price shown).
• Post-transaction holdings: The filing does not state a total common-share balance after these trades; the reporting person additionally holds options to purchase 99,320 shares and 6,500 restricted stock units (footnote F3).
• Transaction codes: M = exercise/conversion of derivative; S = sale in the open market.

Context
This is an exercise of vested options followed by an immediate sale of the acquired shares (commonly called a cashless or simultaneous exercise-and-sell). Sales are often routine liquidity events for insiders and do not, by themselves, indicate company performance. The filing appears timely under Form 4 rules.